Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 J+Rheumatol 2015 ; 42 (11): 2168-71 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Connective Tissue Disease-associated Interstitial Lung Diseases?Report from OMERACT CTD-ILD Working Group #MMPMID25729034
J Rheumatol 2015[Nov]; 42 (11): 2168-71 PMID25729034show ga
Objectives: Interstitial lung disease (ILD) is common in connective tissue disease (CTD) and is the leading cause of mortality. Investigators have used certain outcome measures in randomized controlled trials (RCTs) in CTD-ILD, but the lack of a systematically-developed, CTD-specific index that captures all measures, relevant and meaningful to CTD-ILD patients, has left a large and conspicuous gap in CTD-ILD research. Methods: The CTD-ILD Working Group, under the aegis of OMERACT, has completed a consensus group exercise to reach harmony on core domains and items for inclusion in RCTs in CTD-ILD. During the OMERACT 12 meeting, consensus was sought after on the domains and core items for inclusion in RCTs. In addition, consensus was pursued on efinition of response in RCTs. Consensus was defined as ? 75% consensus. Results: OMERACT 12 participants endorsed the domains with minimal modifications. Clinically meaningful progression for CTD-ILD was proposed as ?10% relative decline in forced vital capacity (FVC)% or ?5?<10% relative decline in FVC% and ?15% relative decline in diffusion capacity in carbon monoxide (DLCO)%. Conclusion: There is consensus on the domains for inclusion in RCTs in CTD-ILD and definition of clinically meaningful progression. Data-driven approaches will need to validate this in different cohorts and RCTs.